Results for "Firefly Bio"

2 stories found

BusinessYahoonaftemporikiseeking-alpha2mo ago3 sources

Johnson & Johnson Acquires Firefly Bio for $1 Billion

Johnson & Johnson has announced its acquisition of Firefly Bio, a company specializing in cancer drug technology development, for $1 billion in cash. This strategic move aims to bolster J&J's oncology pipeline.

BusinessYahooseeking-alpha2mo ago2 sources

J&J to Acquire Firefly Bio for $1 Billion, Incyte Buys Vega Therapeutics

Johnson & Johnson is set to acquire cancer drug technology developer Firefly Bio for $1 billion, while Incyte announced its acquisition of Vega Therapeutics for $1.25 billion. These deals highlight significant activity in the pharmaceutical and biotechnology sectors.